Lexaria Bioscience (LEXX) Return on Assets [ROA] (2018 - 2026)
Lexaria Bioscience (LEXX) recorded Return on Assets [ROA] of -137.38% in fiscal Q3 2026 (quarter ended May 31, 2026), up 10.50 percentage points from -147.88% a year earlier and up 14.76 percentage points from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Return on Assets [ROA] (2018 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Lexaria Bioscience reported Return on Assets [ROA] of -182.65%, down 85.45 percentage points from FY2024.
- Annual Return on Assets [ROA] has a five-year change of -152.85 percentage points (FY2020 to FY2025).
- Across earlier fiscal years, Return on Assets [ROA] came in at -97.20% in FY2024 (+25.76 pp), -122.96% in FY2023 (-52.98 pp), -69.98% in FY2022 (-64.77 pp) and -5.22% in FY2021 (+24.58 pp).
- The fiscal Q3 2026 figure is the highest quarterly Return on Assets [ROA] since fiscal Q2 2025.
- On a year-over-year basis, Return on Assets [ROA] rose in three of the last eight quarters, with an average year-over-year change of -34.89 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 112.27 percentage points in fiscal Q4 2024, against a drop of 169.20 percentage points in fiscal Q4 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -152.15% (Q2 2026), -211.27% (Q1 2026) and -218.23% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Lexaria Bioscience | 3.26 Mn | -12.39 Mn | - | -137.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -137.38% |
| Feb 28, 2026 | -152.15% |
| Nov 30, 2025 | -211.27% |
| Aug 31, 2025 | -218.23% |
| May 31, 2025 | -147.88% |
| Feb 28, 2025 | -101.72% |
| Nov 30, 2024 | -78.56% |
| Aug 31, 2024 | -49.02% |
| May 31, 2024 | -45.10% |
| Feb 29, 2024 | -86.00% |
| Nov 30, 2023 | -147.49% |
| Aug 31, 2023 | -161.29% |
| May 31, 2023 | -138.23% |
| Feb 28, 2023 | -126.69% |
| Nov 30, 2022 | -101.79% |
| Aug 31, 2022 | -39.69% |
| May 31, 2022 | -45.98% |
| Feb 28, 2022 | -42.08% |
| Nov 30, 2021 | -36.41% |
| Aug 31, 2021 | -47.21% |
API Access
Lexaria Bioscience Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();